Ingevity Corporation
NYSE:NGVTChemicals - Specialty
+$0.81 today
- Market cap
- $1.97B
- Beta
- 1.19
- P/E (TTM)
- -20.0
- EPS (TTM)
- -$3.62
Volume 0.37M
Average 0.26M
NGVT Account Payables
Amounts the company owes suppliers for goods and services received.
Ingevity CorporationNYSE: NGVT
Account Payables · Q3 FY2026 · quarter ended Sep 2026
Account payables falls 18.3% from a year ago
Account payables stood at $82.4M at the end of Q3 FY2026, down 18.3% from a year earlier and down 6.4% from the prior quarter. Over 3 fiscal years it compounded at -19.3% a year.
Context
- Account payables amounted to 5.5% of total assets at the end of Q3 FY2026, unchanged from a year earlier.
- Account payables increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps falling in the next quarterly balance sheet after a -18.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 92M USD
- Year-over-year change
- -2.6%
- 4-year CAGR
- -7.5%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 92M | -2.6% |
| FY2024 | 2024-12-31 | 94.5M | -40.3% |
| FY2023 | 2023-12-31 | 158.4M | -9.4% |
| FY2022 | 2022-12-31 | 174.8M | +39.0% |
| FY2021 | 2021-12-31 | 125.8M | — |
Account Payables vs competitors
How NGVT compares with its peers on the latest reported figures
- Peers report in different currencies, so account payables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -18.3% is the 10th highest of 11, against a peer median of +6.1%.
- Account payables amounts to 5.5% of total assets for NGVT, versus a peer median of 7.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $910.3M USD | +1.0% | -1.3% | 12.2% | |
| Jun 2026 | $907M USD | -8.8% | -8.4% | 12.7% | |
| Mar 2026 | $634.1M USD | -20.9% | -14.9% | 6.7% | |
| Sep 2026 | $233.81M USD | +13.8% | +0.8% | 8.0% | |
| Apr 2026 | $199.7M USD | +5.2% | -1.0% | 5.8% | |
| Jun 2026 | $198M USD | +7.0% | -10.7% | 4.3% | |
| Jun 2026 | $169.4M USD | +13.4% | +1.9% | 9.2% | |
AAUCAllied Gold Corporation | Jun 2026 | $164.08M USD | +65.1% | +18.9% | 7.5% |
| Sep 2026 | CA$135.85M CAD | +118.3% | — | 6.9% | |
| Sep 2026 | $82.4M USD | -18.3% | -19.3% | 5.5% | |
ELVRElevra Lithium Limited | Jun 2026 | A$24.29M AUD | -12.6% | +9.1% | 1.8% |
| Peer median (excluding NGVT) | — | +6.1% | -1.0% | 7.2% | |
Competitors are the stored peer set for NGVT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 275.4M | 76.7M | 95.9M | 68M | 78.1M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 191.4M | 249.3M | 211M | 162.7M | 157.8M |
| Inventory | 241.2M | 335M | 308.8M | 195.9M | 186M |
| Other Current Assets | 7.1M | 12.5M | 33.4M | 58.8M | 23.6M |
| Total Current Assets | 724.9M | 683.3M | 658.6M | 493.2M | 454.2M |
| Property, Plant & Equipment (Net) | 772.1M | 855.2M | 829.3M | 687.6M | 637.6M |
| Goodwill | 442M | 518.5M | 527.5M | 175.2M | 4.3M |
| Intangible Assets | 378.7M | 455.8M | 385.3M | 323.9M | 215.5M |
| Long-term Investments | 35.3M | 109.8M | 99.2M | 87.3M | 83.1M |
| Tax Assets | 6.8M | 5.7M | 11.6M | 117.9M | 117M |
| Other Non-current Assets | 109.2M | 108.2M | 111.8M | 137.5M | 139.4M |
| Total Non-current Assets | 1.74B | 2.05B | 1.96B | 1.53B | 1.2B |
| Total Assets | 2.47B | 2.74B | 2.62B | 2.02B | 1.65B |
| Account Payables | 125.8M | 174.8M | 158.4M | 94.5M | 92M |
| Short-term Debt | 19.6M | 900K | 84.4M | 61.3M | 47.1M |
| Tax Payables | 14.4M | 8.9M | 16.7M | 5.6M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.1M | 6.9M | 15.1M | 500K | 14.7M |
| Total Current Liabilities | 268.9M | 303.5M | 362.9M | 264.1M | 341.3M |
| Long-term Debt | 1.25B | 1.47B | 1.38B | 1.24B | 1.06B |
| Deferred Tax Liabilities | 114.6M | 106.5M | 70.9M | 56.2M | 57.3M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 125.5M | 114.9M | 126.7M | 130.6M | 39M |
| Total Non-current Liabilities | 1.53B | 1.73B | 1.63B | 1.56B | 1.28B |
| Total Liabilities | 1.8B | 2.04B | 1.99B | 1.83B | 1.62B |
| Common Stock | 400K | 400K | 400K | 400K | 400K |
| Retained Earnings | 796.1M | 1.01B | 1B | 572M | 404.9M |
| Accumulated OCI | 13.1M | (46.8M) | (26.7M) | (41.4M) | 500K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 673.8M | 698.3M | 631.4M | 195.2M | 29.7M |
| Total Debt | 1.32B | 1.53B | 1.53B | 1.45B | 1.24B |
| Net Debt | 1.05B | 1.45B | 1.44B | 1.39B | 1.16B |
Ingevity Corporation
NYSE:NGVT
Intrinsic Alpha fair value
Locked
Current Price
$58.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.